Predictive value of collagen biomarkers for heart failure with and without preserved ejection fraction: MESA (Multi-Ethnic Study of Atherosclerosis)

Daniel A. Duprez, Myron D. Gross, Jorge R. Kizer, Joachim H. Ix, William G. Hundley, David R. Jacobs

Research output: Contribution to journalArticlepeer-review

50 Scopus citations


Background--Collagen biomarkers may correlate with incident heart failure (HF) and its subtypes. We hypothesized that circulating procollagen type III N-terminal propeptide (PIIINP) and collagen type I carboxy-terminal telopeptide (ICTP) predict incident HF. Methods and Results--We used a stratified sampling design in a multiethnic sample of 3187 subjects, initially aged 45 to 84 years and free of cardiovascular disease. We assayed baseline serum PIIINP and ICTP concentrations using radioimmunoassay. Incident HF was adjudicated, distinguishing reduced ejection fraction (HFrEF; EF < 45%) from preserved EF (HFpEF; EF =45%). The incidence density for HFpEF and HFrEF was computed using Poisson regression per SD for each of PIIINP and ICTP, adjusting in model 1 for age, race, sex, and renal function or in model 2 for these variables plus blood pressure and medication. Mean (SD) ICTP was 3.38±1.77 lg/L, and mean (SD) PIIINP was 5.48±2.04 lg/L. Among the HF cases, 96 were HFrEF and 107 were HFpEF. Neither ICTP nor PIIINP significantly predicted incident HFrEF. The incidence density for HFpEF per 100 people observed for 13 years was 1.65 for low PIIINP (lower 6 octiles) versus 3.00 for higher PIIINP (P=0.002) in model 1 and correspondingly 1.45 versus 2.59 (P=0.003) in model 2. For low ICTP (lower 7 octiles) versus higher ICTP (octile 8), incidence densities were 1.79 versus 3.64 (P=0.002) in model 1 and 1.58 versus 3.12 (P=0.002) in model 2. Conclusions--High levels of circulating ICTP and PIIINP as collagen biomarkers appear to be associated with incident HFpEF, but not HFrEF.

Original languageEnglish (US)
Article numbere007885
JournalJournal of the American Heart Association
Issue number5
StatePublished - Mar 6 2018

Bibliographical note

Funding Information:
MESA (Multi-Ethnic Study of Atherosclerosis) was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169 from the National Heart, Lung, and Blood Institute and by grants UL1-TR-000040 and UL1-TR-001079 from the National Center for Research Resources (the last 2 are Clinical and Translational Science Institute acknowledgements from Columbia and Johns Hopkins University). Collagen biomarkers were funded by R01 HL098382 from the National Heart, Lung, and Blood Institute (Jacobs and Duprez).

Publisher Copyright:
© 2018 The Authors.


  • Collagen type I carboxy-terminal telopeptide
  • Diastolic dysfunction
  • Fibrosis
  • Procollagen type III N-terminal propeptide
  • Systolic dysfunction


Dive into the research topics of 'Predictive value of collagen biomarkers for heart failure with and without preserved ejection fraction: MESA (Multi-Ethnic Study of Atherosclerosis)'. Together they form a unique fingerprint.

Cite this